Comparison

Deferasirox Impurity E

Item no. TRC-D228710-50mg
Manufacturer Toronto Research Chemicals
CASRN 1688656-83-8
Amount 50 mg
Quantity options 10 mg 50 mg 5 mg
Category
Type Biochemicals
Specific against other
InCHI 1S/C42H28N6O8S/c49-33-7-3-1-5-29(33)39-43-37(45-47(39)25-13-9-23(10-14-25)41(53)54)31-21-27(17-19-35(31)51)57-28-18-20-36(52)32(22-28)38-44-40(30-6-2-4-8-34(30)50)48(46-38)26-15-11-24(12-16-26)42(55)56/h1-22,49-52H,(H,53,54)(H,55,56)
Smiles OC(C=CC(SC1=CC=C(O)C(C2=NN(C3=CC=C(C(O)=O)C=C3)C(C4=CC=CC=C4O)=N2)=C1)=C5)=C5C6=NN(C7=CC=C(C(O)=O)C=C7)C(C8=CC=CC=C8O)=N6
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Deferasirox Impurity E; Bis[3-[1-(4-Carboxyphenyl)-5-(2-hydroxyphenyl)-1H-1,2,4-triazol-3-yl]-4-hydroxyphenyl] Sulfide; 4-[3-[5-[3-[1-(4-Carboxyphenyl)-5-(2-hydroxyphenyl)-1,2,4-triazol-3-yl]-4-hydroxy-phenyl]sulfanyl-2-hydroxy-phenyl]-5-(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benz
Available
Mol. Weight
776, 772
Country of Origin
Canada
IUPAC
4-[3-[5-[3-[1-(4-carboxyphenyl)-5-(2-hydroxyphenyl)-1, 2, 4-triazol-3-yl]-4-hydroxyphenyl]sulfanyl-2-hydroxyphenyl]-5-(2-hydroxyphenyl)-1, 2, 4-triazol-1-yl]benzoic acid
Shipping Condition
RT
Manufacturers Category
Standards; Pharmaceutical/API Drug Impurities/Metabolites;

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close